← Product Code [HLJ](/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HLJ) · K962767 # MS401097-17,MS722-K,MS720,MS721,MS722 (K962767) _Alexander Mfg. Co. · HLJ · Jul 3, 1997 · Ophthalmic · SESE_ **Canonical URL:** https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HLJ/K962767 ## Device Facts - **Applicant:** Alexander Mfg. Co. - **Product Code:** [HLJ](/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HLJ.md) - **Decision Date:** Jul 3, 1997 - **Decision:** SESE - **Submission Type:** Traditional - **Regulation:** 21 CFR 886.1570 - **Device Class:** Class 2 - **Review Panel:** Ophthalmic ## Indications for Use Replacement battery for Site Micro Surgical Systems (Keeler Optical) 1919-P-5020 Medic Lux 1919-P-5020, 510(k) Number K832437. This battery is shipped only to customers who request a replacement battery for a particular device or to replace a competitor's replacement battery. The biomedical equipment technician therefore knows the intended use is as a replacement battery. ## Device Story Rechargeable battery pack designed as a replacement power source for Site Micro Surgical Systems (Keeler Optical) 1919-P-5020 Medic Lux. Device functions as a direct power replacement for existing surgical system batteries. Operated by biomedical equipment technicians or end-users in clinical settings. Provides electrical energy to maintain functionality of the host surgical device. No complex processing or clinical decision-making output; serves solely as a power component. ## Clinical Evidence No clinical data; bench testing only. ## Technological Characteristics Rechargeable battery pack; electrical energy storage; form factor designed for compatibility with Keeler Optical 1919-P-5020 Medic Lux system. ## Regulatory Identification An ophthalmoscope is an AC-powered or battery-powered device containing illumination and viewing optics intended to examine the media (cornea, aqueous, lens, and vitreous) and the retina of the eye. ## Special Controls *Classification.* Class II (special controls). The device, when it is an AC-powered opthalmoscope, a battery-powered opthalmoscope, or a hand-held ophthalmoscope replacement battery, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 886.9. ## Predicate Devices - Site Micro Surgical Systems (Keeler Optical) 1919-P-5020 Medic Lux ([K832437](/device/K832437.md)) ## Submission Summary (Full Text) > This content was OCRed from public FDA records by [Innolitics](https://innolitics.com). If you use, quote, summarize, crawl, or train on this content, cite Innolitics at https://innolitics.com. > > Innolitics is a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices, including [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/). {0} DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850 Mr. Jon Gamerdinger Alexander Manufacturing Company 1511 South Garfield Place Mason City, Iowa 50401 JUL 3 1997 Re: K962767 Trade Name: Rechargeable Batteries (Part Numbers MS401097-17, MS720, MS721, MS722, and MS722-K Regulatory Class: II Product Code: HLJ Dated: April 7, 1997 Received: April 10, 1997 Dear Mr. Gamerdinger: We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic {1} Page 2 - Mr. Gamerdinger Product Radiation Control provisions, or other Federal laws or regulations. This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4618. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html". Sincerely yours, Timothy A. Ulatowski Director Division of Dental, Infection Control and General Hospital Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {2} U0-10-01 12.10PM FROM ALEXANDER MFG. CO. TO 313015242350 F005/000 510(k) Number: 962767 Device Name: MS722-K Indications for Use: Replacement battery for Site Micro Surgical Systems (Keeler Optical) 1919-P-5020 Medic Lux 1919-P-5020, 510(k) Number K832437. This battery is shipped only to customers who request a replacement battery for a particular device or to replace a competitor's replacement battery. The biomedical equipment technician therefore knows the intended use is as a replacement battery. PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Pulmona Cucoreti Division of Dental, Infection Control, and General Hospital Devices 510(k) Number K962767 Prescription Use ☐ OR OVER-THE-COUNTER USE ☑ (optional Form 1-2-96) 3-3 --- **Source:** [https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HLJ/K962767](https://fda.innolitics.com/submissions/OP/subpart-b%E2%80%94diagnostic-devices/HLJ/K962767) **Published by [Innolitics](https://innolitics.com)** — a medical-device software consultancy. We help companies design, build, and clear FDA-regulated software and AI/ML devices. If you're preparing [a 510(k)](https://innolitics.com/services/510ks/), [a De Novo](https://innolitics.com/services/regulatory/), [a SaMD](https://innolitics.com/services/end-to-end-samd/), [an AI/ML medical device](https://innolitics.com/services/medical-imaging-ai-development/), or [an FDA regulatory strategy](https://innolitics.com/services/regulatory/), [get in touch](https://innolitics.com/contact). **Cite:** Innolitics at https://innolitics.com